We are independent consultants who help clients with their pharmaceutical product development and medical communications needs.
Mathew Lo, PhD
Mary Conrad Lo, MD
We support clients in the USA, the UK and EU, and several Asian countries with a variety of projects.
Our assistance ranges from providing strategic planning and management advice to actual production of regulatory documents and manuscripts, whether what’s needed is a single document or an entire regulatory submission.
We draw on our expertise and past experience to help clients prepare for consultations with regulatory authorities.
For larger projects, we call upon our extensive network of highly experienced professional colleagues (MDs and PhDs) as external resources.
Our rates are competitive and negotiated, and contractual relationships are fully documented prior to beginning projects.
WHO WE ARE
Early in our careers, we were happy for the opportunity to do some neuroscience research together. In 2013, we decided to team up again and form our company. Now, we really enjoy working with our clients on their projects.
Prior to being self-employed, Mathew was the Senior Vice President of Global Research & Development at Savant HWP, Inc. In this capacity, reporting to the CEO, he was accountable for managing all aspects of producing the data package and regulatory filings for 18-MC (addiction) and benznidazole (Chagas Disease). From 1989 to 2012, Mathew held various positions at AstraZeneca and MedImmune, in Drug Discovery, Clinical Development and International Sales and Marketing, including that of Senior Director and Product Development Team Leader at MedImmune (an AstraZeneca subsidiary). Mathew completed his PhD at Imperial College, University of London, in 1980. He was a postdoctoral fellow at the Johns Hopkins University School of Medicine from 1981 to 1985, and held an intramural research position at the National Institute on Drug Abuse and Addiction Research Center until 1989.
Mary has been editing manuscripts, mainly for researchers for whom English is a second language, since 2004. She worked for four years in basic medical research at the Johns Hopkins University School of Medicine, departments of Immunology, Neuroscience, and Pathology, and for one year at Duke University School of Medicine, department of Immunology, before completing her MD degree at the University of Maryland and PGY 1 at the Sheppard and Enoch Pratt Hospital. After that she returned to basic neuroscience research, working with Mathew at the National Institute on Drug Abuse and Addiction Research Center. She was introduced to the field of medical writing during their new family’s two-year secondment with AstraZeneca to the UK, where she edited regulatory documents for a contract research organization (CRO). She thoroughly enjoys combining a lifelong interest in language and writing with her scientific and medical training to help clients achieve their goals.